RESULTS FROM A PHASE I/II CLINICAL TRIAL ON ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR GENE THERAPY IN PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION

被引:0
|
作者
Lai, Chooi-May [1 ]
Magno, Aaron [2 ]
Pierce, Cora [2 ]
Samulski, Richard J. [3 ,4 ]
Chalberg, Thomas W. [5 ]
Blumenkranz, Mark S. [6 ]
Constable, Ian J. [1 ]
Rakoczy, Elizabeth P. [1 ]
机构
[1] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Crawley, WA, Australia
[2] Lions Eye Inst, Nedlands, WA, Australia
[3] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA
[4] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC USA
[5] Avalanche Biotechnol, San Francisco, CA USA
[6] Byers Eye Inst Stanford, Palo Alto, CA USA
来源
JOURNAL OF GENE MEDICINE | 2013年 / 15卷 / 8-9期
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:319 / 319
页数:1
相关论文
共 50 条
  • [11] Therapy of Age-related Exudative Macular Degeneration with Anti-vascular Endothelial Growth Factor Drugs: An Italian Real Life Study
    Rossi, Settimio
    Gesualdo, Carlo
    Tartaglione, Antonio
    Scazzi, Giovan Battista
    D'Alessio, Anna Cristina
    Ragucci, Adele
    Melillo, Paolo
    Simonelli, Francesca
    OPEN OPHTHALMOLOGY JOURNAL, 2021, 15 : 130 - 136
  • [12] Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration - Phase II study results
    Fish, G
    Haller, JA
    Ho, AC
    Klein, M
    Loewenstein, J
    Martin, D
    Orth, D
    Rosen, RB
    Sanislo, S
    Schwartz, SD
    Singerman, LJ
    Williams, G
    Adamis, AP
    Blumenkranz, M
    Goldberg, M
    Gragoudas, ES
    Miller, JW
    Yannuzzi, L
    Guyer, DR
    O'Shaughnessy, D
    Patel, S
    OPHTHALMOLOGY, 2003, 110 (05) : 979 - 986
  • [13] Recurrent Tube Erosions with Anti-Vascular Endothelial Growth Factor Therapy in Patients with Age-Related Macular Degeneration
    Liu, Katy C.
    Gomez-Caraballo, Maria
    Challa, Pratap
    Asrani, Sanjay G.
    OPHTHALMOLOGY GLAUCOMA, 2020, 3 (04): : 295 - 300
  • [14] Seven-year outcomes following intensive anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration
    Regina Lukacs
    Miklos Schneider
    Zoltan Zsolt Nagy
    Gabor Laszlo Sandor
    Kinga Kaan
    Antonia Asztalos
    Lajos Enyedi
    Gyorgy Pek
    Gyorgy Barcsay
    Antal Szabo
    Agnes Borbandy
    Illes Kovacs
    Miklos Denes Resch
    Andras Papp
    BMC Ophthalmology, 23
  • [15] Seven-year outcomes following intensive anti-vascular endothelial growth factor therapy in patients with exudative age-related macular degeneration
    Lukacs, Regina
    Schneider, Miklos
    Nagy, Zoltan Zsolt
    Sandor, Gabor Laszlo
    Kaan, Kinga
    Asztalos, Antonia
    Enyedi, Lajos
    Pek, Gyorgy
    Barcsay, Gyorgy
    Szabo, Antal
    Borbandy, Agnes
    Kovacs, Illes
    Resch, Miklos Denes
    Papp, Andras
    BMC OPHTHALMOLOGY, 2023, 23 (01)
  • [16] VITREOMACULAR TRACTION AFFECTS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OUTCOMES FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
    Krishnan, Radhika
    Arora, Rashi
    De Salvo, Gabriella
    Stinghe, Alina
    Severn, Philip S.
    Pal, Bishwanath
    Goverdhan, Srinivas
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (09): : 1750 - 1756
  • [17] Anti-Vascular Endothelial Growth Factor (VEGF) Treatment of Age-Related Macular Degeneration
    Bolling, James P.
    CURRENT DRUG THERAPY, 2012, 7 (02) : 90 - 95
  • [18] Status of Usage of Anti-vascular Endothelial Growth Factor in Age-related Macular Degeneration
    Cho, Songhee
    Shin, Sang Jin
    Suh, Jae Kyung
    Tchoe, Hajin
    Kang, Min Joo
    Yang, Jangmi
    Jee, Donghyun
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2019, 60 (08): : 758 - 764
  • [19] Implications of discontinuing anti-vascular endothelial growth factor therapy in neovascular age-related macular degeneration
    Chang, Andrew A.
    Spooner, Kimberly
    Fraser-Bell, Samantha
    Hong, Thomas
    Wong, James G.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 49 (08): : 956 - 956
  • [20] Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration
    Vedula, S. S.
    Krzystolik, M. G.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (02):